We are live on ! Find out more
ME

McIlrath & Eck Portfolio holdings

AUM $1.35B
1-Year Est. Return 15.78%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+15.78%
3 Year Est. Return
+43.95%
5 Year Est. Return
+48.52%
10 Year Est. Return
AUM
$370M
AUM Growth
+$33.9M
Cap. Flow
+$9.04M
Cap. Flow %
2.45%
Top 10 Hldgs %
81.1%
Holding
864
New
33
Increased
105
Reduced
147
Closed
43

Sector Composition

Rank Sector Weight
1 Technology 14.11%
2 Financials 2.64%
3 Consumer Discretionary 1.9%
4 Industrials 1.8%
5 Communication Services 1.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BV icon
501
BrightView Holdings
BV
$1.22B
$12K ﹤0.01%
860
-275
-24% -$4.14K
VISN
502
Vistance Networks Inc
VISN
$2.65B
$12K ﹤0.01%
1,100
EDIT icon
503
Editas Medicine
EDIT
$396M
$12K ﹤0.01%
460
EOG icon
504
EOG Resources
EOG
$79.2B
$12K ﹤0.01%
134
IDV icon
505
iShares International Select Dividend ETF
IDV
$8.45B
$12K ﹤0.01%
375
NET icon
506
Cloudflare
NET
$99B
$12K ﹤0.01%
93
OXY icon
507
Occidental Petroleum
OXY
$56.8B
$12K ﹤0.01%
400
PCH
508
DELISTED
PotlatchDeltic
PCH
$12K ﹤0.01%
192
SBAC icon
509
SBA Communications
SBAC
$19.2B
$12K ﹤0.01%
30
SCHM icon
510
Schwab US Mid-Cap ETF
SCHM
$14.5B
$12K ﹤0.01%
459
-366
-44% -$9.76K
TRMK icon
511
Trustmark
TRMK
$2.76B
$12K ﹤0.01%
381
VMC icon
512
Vulcan Materials
VMC
$34.8B
$12K ﹤0.01%
57
VTR icon
513
Ventas
VTR
$48B
$12K ﹤0.01%
231
VVX icon
514
V2X
VVX
$2.83B
$12K ﹤0.01%
265
-124
-32% -$5.88K
TVRD
515
Tvardi Therapeutics
TVRD
$19.7M
$12K ﹤0.01%
26
VIVO
516
DELISTED
Meridian Bioscience Inc
VIVO
$12K ﹤0.01%
570
AROW icon
517
Arrow Financial
AROW
$659M
$11K ﹤0.01%
343
LONA
518
LeonaBio Inc
LONA
$66.3M
$11K ﹤0.01%
+83
New +$10.5K
CHE icon
519
Chemed
CHE
$7.07B
$11K ﹤0.01%
+21
New +$10.1K
CRL icon
520
Charles River Laboratories
CRL
$11.2B
$11K ﹤0.01%
28
DDOG icon
521
Datadog
DDOG
$95.4B
$11K ﹤0.01%
60
DXCM icon
522
DexCom
DXCM
$31.5B
$11K ﹤0.01%
80
IEFA icon
523
iShares Core MSCI EAFE ETF
IEFA
$190B
$11K ﹤0.01%
151
JWN
524
DELISTED
Nordstrom
JWN
$11K ﹤0.01%
482
-730
-60% -$19.3K
KHC icon
525
Kraft Heinz
KHC
$30.7B
$11K ﹤0.01%
319
+150
+89% +$5.39K

Similar funds

McIlrath & Eck's Q4 2021 Portfolio in Review

As of Q4 2021, McIlrath & Eck held 864 positions worth $370M, up 10% from $336M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

McIlrath & Eck's Q4 2021 filing shows 33 new, 105 increased, 147 reduced and 43 closed positions. Its largest new stake was iShares Core Moderate Allocation ETF: 3,435 shares worth $156K. The largest sale was Vanguard Morningstar Growth ETF, an estimated $1.92M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

  • McIlrath & Eck's largest Q4 2021 buy was iShares Core Moderate Allocation ETF: 3,435 shares worth $156K.
  • McIlrath & Eck added most to Vanguard Short-Term Corporate Bond ETF in Q4 2021, an estimated $6.19M increase.
  • McIlrath & Eck's biggest Q4 2021 reduction was Vanguard Morningstar Growth ETF, cutting an estimated $1.92M.
  • McIlrath & Eck fully exited Citigroup in Q4 2021, selling an estimated $141K.
  • McIlrath & Eck's ten largest holdings make up 81% of its $370M portfolio in Q4 2021.
  • McIlrath & Eck opened 33 new positions and closed 43 in Q4 2021.
  • McIlrath & Eck's portfolio value rose 10% quarter-over-quarter to $370M.

Based on McIlrath & Eck's 13F filing for Q4 2021, filed 8 Feb 2022.